Will Cannabis Genetics

Will Cannabis Genetics Be Restricted?
The redefinition of hemp under national law, set to take effect Nov. 12, signals the end of Farm Bill protections for many hemp-derived THC items across the nation: low-dose beverages as well as THCA bud and delta-8 THC gummies, vapes and additional products sold at gas stations and smoke shops.

But the hemp ban also creates a significant complication for the legitimate cannabis industry. Seeds from cannabis varieties that produce flower with greater than 0.3% THC are no longer legal to transport out of state.

Although seed purchases will probably continue in authorized states, the changes threaten to close some seed suppliers and genetics companies, observers note, while causing supply-chain issues for cannabis cultivators and retailers.

"If this wording goes through, we will need pop-up shops to sell seeds in each state where it's legal," Campanella said. "Which is why we're also offering clones and tissue cultivation, because that's not included in the bill."
When are cannabis seeds and clones prohibited to ship across state lines?
The new regulations categorize seeds depending on the THC capacity of the mother plant. Genetic material such as seeds and clones are made illegal if the final product exceeds the threshold.

For now, seeds are still shipping under the 2018 Farm Bill's current quo. But the time is ticking for enterprises like Brothers Grimm and https://nativesusa.com/ (https://nativesusa.com/) for cannabis cultivators who worry about supply chain interruptions if out-of-state access to genetics is prohibited.

Most of the cannabis sector remains largely unaware of the impending shutdown of the interstate genetics marketplace, said Ryan Power, co-founder of Sebastopol, California-based breeder Atlas Seed.

Without federal intervention in the way of a carve-out for seeds or an overall moratorium, many seed providers will just be shuttered by November, he added.

"We are operating legally now, but if that changes, it will disrupt the legitimate licensed sector in every state," said Power, whose clientele includes seed banks as well as licensed business cultivators.

"Consumers are going to forfeit choice, and it will be a major shutdown for many people."
What are cannabis seed suppliers doing to stay legal after the federal hemp ban?
Sagui Silber has previously recalibrated Silberhaze Genetics, his Ohio genetics company, because of state Senate Bill 56, which strengthened cannabis oversight in that state while also restricting hemp-derived THC products to licensed cannabis retailers.

Formerly a seed bank, Silberhaze is currently focused on the branding, preservation and IP safeguarding of premium plant genetics.

That's because seed companies hoping to remain compliant in this new environment must have solid documentation, he said.

"You have to demonstrate where this material comes from, so it's extremely important to have documentation, even to the extent where you have breeder names," Silber said.

"Smaller businesses will have to work with better records and a better chain of custody," he added. "We want that documentation too, because we don't want to be working with questionable sources."

To prevent seizures and additional legal fallout, seed business owners must "get their ducks in a row" before the new regulations take effect, Silber said.

"Audit all your materials immediately, and categorize what you can," Silber said. "Take inventory, document your lineage, preserve cultivator records, and organize any cannabinoid or terpene information you already have. If regulations change, you'll be in a far better position to understand what may be impacted and make informed decisions."
Does federal marijuana rescheduling impact cannabis genetics?
Silber believes U.S. Drug Enforcement Administration licensing may be necessary for companies engaged in research.

But for now, seed houses can't enroll with the DEA like state-licensed therapeutic cannabis businesses can. Such an option is unavailable to seed suppliers, nurseries or genetics companies, said Jim Ickes, a lawyer and partner with Frantz Ward's cannabis law group in Cleveland.

"Seed-related activity may be happening inside broader state-licensed therapeutic marijuana operations, as some states permit dispensaries or registered therapeutic operators to sell seeds, clones or personal growing materials," he said.

"But that is distinct from the DEA establishing a freestanding seed supplier registration category."

Some genetics companies are already changing operational practices to conform with the new law. According to Ickes, they must answer questions including:
Which of our lines produce plants above 0.3% total THC?Which seeds remain as hemp after Nov. 12, 2026, and which don't?What does our inventory look like once we organize it against the viable-seed exclusion?
Ickes also understands confusion from clients who believed federal rescheduling of therapeutic marijuana would resolve their story with financial institutions. However, the latest regulatory language has shifted those conversations beyond the fundamentals of classification, he said.

"Financial institutions ask whether this specific revenue source is lawful, whether it ties to state-licensed operations, or whether there's interstate-commerce risk," said Ickes.

"After November, a seed supplier selling high-THC genetics can't answer the initial question with the hemp definition. It has to point to a legal state cannabis pathway instead. Seed banks dealing in authentic industrial-hemp seed maintain the simpler story."
What's the outlook of cannabis genetics?
Campanella is part of a emerging coalition of fellow breeders, farmers and researchers that's arguing seeds are more appropriately defined as farm inputs than regulated substances. To that end, seeds should be managed by the U.S. Department of Agriculture, allowing the DEA to focus its enforcement efforts elsewhere.

"How do you regulate something based on what it might become later?" said Campanella. "Our preference is to have that wording removed, or get seeds regulated by the USDA as a hemp product."

But in the meantime, Campanella is restructuring Brothers Grimm to function outside the scope of shifting federal oversight. The company plans to keep its Colorado seed facility while placing its Oklahoma tissue cultivation facility as a safeguard against government prohibition of cannabis seeds.

As she noted: "If things develop in a way where we can't focus on interstate shipping, we'll have other resources to satisfy people's needs without putting ourselves in trouble."